PRQR (PRQR) Stock Price & Analysis
PRQR (PRQR) fell 0.96% to USD 2.07 as of September 8, 2026 at 10:13 UTC, according to Nexqual real-time market data.
PRQR last closed at USD 2.07; the session ranged USD 2.06–2.11 on volume of 368,464 shares. Market capitalization is —, with a 52-week range of USD 1.33–3.1 (NCM). Source: Nexqual, September 8, 2026 at 10:13 UTC.
Key Statistics (as of September 8, 2026 at 10:13 UTC)
| Price | USD 2.07 |
|---|---|
| Change | ▼ 0.96% (down) |
| Previous Close | USD 2.07 |
| Open | USD 2.07 |
| Day Range | USD 2.06 – 2.11 |
| 52-Week Range | USD 1.33 – 3.1 |
| Volume | 368,464 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PRQR)
Nexqual's technical model rates PRQR "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 10:13 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.14 (neutral) |
| vs SMA50 | Above (USD 1.91) |
| MACD | 0.08 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| WVE | Wave Life Sciences, Inc. | USD 4.86 | ▼ 0.41% |
| GLMD | Galmed Pharmaceuticals Ltd. | USD 3.88 | ▼ 5.8% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:13 UTC. This page is informational and not investment advice.